Issue Navigation
-
Review
-
62-74
Perspectives on urological care in multiple sclerosis patients
Moussa M, Abou Chakra M, Papatsoris AG, Dabboucy B, Hsieh M, Dellis A, Fares Y
Intractable Rare Dis Res. 2021; 10(2):62-74.
DOI: 10.5582/irdr.2021.01029
-
75-80
Faldini C, Viroli G, Fiore M, Barile F, Manzetti M, Merlini L, Ruffilli A
Intractable Rare Dis Res. 2021; 10(2):75-80.
DOI: 10.5582/irdr.2020.03162
-
81-87
El-Attar LM, Bahashwan AA, Bakhsh AD, Moshrif YM
Intractable Rare Dis Res. 2021; 10(2):81-87.
DOI: 10.5582/irdr.2021.01016
-
88-94
Widhiati S, Danarti R, Trisnowati N, Purnomosari D, Wibawa T, Soebono H
Intractable Rare Dis Res. 2021; 10(2):88-94.
DOI: 10.5582/irdr.2020.03150
-
95-101
Suzumoto Y, Columbano V, Gervasi L, Giunta R, Mattina T, Trimarchi G, Capolongo G, Simeoni M, Perna AF, Zacchia M, TorielloG, Pollastro RM, Rapisarda F, Capasso G, Trepiccione F
Intractable Rare Dis Res. 2021; 10(2):95-101.
DOI: 10.5582/irdr.2020.03158
-
102-108
A novel BICD2 mutation of a patient with Spinal Muscular Atrophy Lower Extremity Predominant 2
Tumurkhuu M, Batbuyan U, Yuzawa S, Munkhsaikhan Y, Batmunkh G, Nishimura W
Intractable Rare Dis Res. 2021; 10(2):102-108.
DOI: 10.5582/irdr.2021.01004
-
109-113
Loss of miR-23a cluster in skeletal muscle can suppress bone remodeling
Zhang H, Luan J, Cui Y, Han J
Intractable Rare Dis Res. 2021; 10(2):109-113.
DOI: 10.5582/irdr.2021.01054
-
114-121
Yuniati R, Sihombing NRB, Nauphar D, Tiawarman B, Kartikasari DS, Dewi M, Faradz SMH
Intractable Rare Dis Res. 2021; 10(2):114-121.
DOI: 10.5582/irdr.2020.03143
-
122-125
Rituximab use for refractory anti-HMGCR immune-mediated necrotizing myopathy: A case report
Gupta S, Rakhra A, Thallapally V, Nahas J
Intractable Rare Dis Res. 2021; 10(2):122-125.
DOI: 10.5582/irdr.2020.03144
-
126-130
Norioka R, Tobisawa S, Nishigori R, Kuhara T, Yazaki M, Nagao M, Ohura T, Takai Y, Funai A,Miyamoto K, Kawata A, Takahashi K
Intractable Rare Dis Res. 2021; 10(2):126-130.
DOI: 10.5582/irdr.2021.01003
-
131-135
Salemis NS
Intractable Rare Dis Res. 2021; 10(2):131-135.
DOI: 10.5582/irdr.2021.01017
-
136-141
Bolcato V, Carelli C, VisonĂ SD, Reguzzoni M, Di Rocco M, Radogna A, Tronconi LP, Moretti M
Intractable Rare Dis Res. 2021; 10(2):136-141.
DOI: 10.5582/irdr.2021.01021
-
142-145
Honda D, Ohsawa I, Mano S, Rinno H, Tomino Y, Suzuki Y
Intractable Rare Dis Res. 2021; 10(2):142-145.
DOI: 10.5582/irdr.2021.01010
-
146-147
Orphan drugs in different countries and development of new drugs to treat biliary tract cancer
Cheng HH, Zhou D, Wang SH, Ding Jun, Ma F
Intractable Rare Dis Res. 2021; 10(2):146-147.
DOI: 10.5582/irdr.2021.01038